ADM
33
2
T
42
3
ALLE
35
3
EW
36
2
ETR
77
-2
ECL
55
-4
ZBH
80
14
CMCSA
35
3
MU
59
5
AIV
44
-2
VIX
38
-6
BIIB
33
-2
AZO
50
5
MUR
30
-4
FAST
55
3
VFC
70
-2
AN
65
2
BRK.B
38
4
ADI
60
3
ROK
40
2
ADM
33
2
T
42
3
ALLE
35
3
EW
36
2
ETR
77
-2
ECL
55
-4
ZBH
80
14
CMCSA
35
3
MU
59
5
AIV
44
-2
VIX
38
-6
BIIB
33
-2
AZO
50
5
MUR
30
-4
FAST
55
3
VFC
70
-2
AN
65
2
BRK.B
38
4
ADI
60
3
ROK
40
2
Financhill
Back

Rigel Pharmaceuticals 10K Form

Sell
36

RIGL
Rigel Pharmaceuticals

Last Price:
$20.23
Seasonality Move:
-6.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-07 10Q RIGL/Rigel Pharmaceuticals Quarterly
2023-11-07 10Q RIGL/Rigel Pharmaceuticals Quarterly
2023-08-01 10Q RIGL/Rigel Pharmaceuticals Quarterly
2023-05-02 10Q RIGL/Rigel Pharmaceuticals Quarterly
2022-11-03 10Q RIGL/Rigel Pharmaceuticals Quarterly
2022-08-02 10Q RIGL/Rigel Pharmaceuticals Quarterly

Receive RIGL News And Ratings

See the #1 stock for the next 7 days that we like better than RIGL

RIGL Financial Statistics

Sales & Book Value

Annual Sales: $116.9M
Cash Flow: $21.7M
Price / Cash Flow: 34.09
Annual Sales: $-0.83
Price / Book: 0

Profitability

EPS (TTM): 0.23000
Net Income (TTM): $3.9M
Gross Margin: $109.8M
Return on Equity: 0%
Return on Assets: 3.1%

Rigel Pharmaceuticals Earnings Forecast

Key Rigel Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 25 years for RIGL is 93.92%.
  • The Selling, General & Administrative Expenses for RIGL have been equal to 90.47% of Gross Profit Margin.
  • The Research & Development expenses have been 20.98% of Revenue.
  • The Net Earning history of RIGL is -21.47% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 17 years.

Rigel Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RIGL
CUSIP: 766559
Website: rigel.com

Debt

Debt-to-Equity Ratio: -4.08
Current Ratio: 1.96
Quick Ratio: 1.69

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 10.3

RIGL Technical Analysis vs Fundamental Analysis

Sell
36
Rigel Pharmaceuticals (RIGL) is a Sell

Is Rigel Pharmaceuticals a Buy or a Sell?